Roll Call February 2, 2023
By Sandhya Raman, Lauren Clason, Jessie Hellmann, and Ariel Cohen

The Biden administration’s decision to end the COVID-19 PHE will impact everything from cost of vaccines to Medicaid eligibility

The Biden administration’s plan to unwind the public health emergency tied to the COVID-19 pandemic will spur a whirlwind of changes related to telehealth, Medicaid, pharmaceuticals and other priorities.

Many Republicans have said the May 11 end date announced Monday is not soon enough, with the House voting this week on a bill to roll back that and three other pandemic policies immediately. Democrats have said the time is needed to weigh which flexibilities and funding may need to continue.

Still, U.S. plans to end the emergencies stand in contrast to the opinions of other global health leaders, with...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Healthcare System, Insurance, Medicaid, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health / COVID
WHO Warns Threat Of Bird Flu Spreading To Humans Is ‘Great Concern’
Can DNA Tests Promote Colorectal Cancer Screening?
Are We FLiRTing With A New Covid Wave?
New pandemic plan’s a lot like the old one
Exclusive: More trust themselves to make health decisions

Share This Article